Shariat SF - Search Results

1

Urinary cytology and nuclear matrix protein 22 in the detection of bladder cancer recurrence other than transitional cell carcinoma.

Hutterer GC, Karakiewicz PI, Zippe C, Lüdecke G, Boman H, Sanchez-Carbayo M, Casella R, Mian C, Friedrich MG, Eissa S, Akaza H, Serretta V, Hedelin H, Rupesh R, Miyanaga N, Sagalowsky AI, Perrotte P, Lotan Y, Marberger MJ, Shariat SF. Hutterer GC, et al. Among authors: shariat sf. BJU Int. 2008 Mar;101(5):561-5. doi: 10.1111/j.1464-410X.2007.07352.x. BJU Int. 2008. PMID: 18257856

2

Prostate specific antigen density of the transition zone for early detection of prostate cancer.

Djavan B, Zlotta AR, Byttebier G, Shariat S, Omar M, Schulman CC, Marberger M. Djavan B, et al. J Urol. 1998 Aug;160(2):411-8; discussion 418-9. J Urol. 1998. PMID: 9679889

3

Urinary levels of urokinase-type plasminogen activator and its receptor in the detection of bladder carcinoma.

Casella R, Shariat SF, Monoski MA, Lerner SP. Casella R, et al. Among authors: shariat sf. Cancer. 2002 Dec 15;95(12):2494-9. doi: 10.1002/cncr.10989. Cancer. 2002. PMID: 12467062 Free article.

4

The addition of urinary urokinase-type plasminogen activator to urinary nuclear matrix protein 22 and cytology improves the detection of bladder cancer.

Shariat SF, Casella R, Monoski MA, Sulser T, Gasser TC, Lerner SP. Shariat SF, et al. J Urol. 2003 Dec;170(6 Pt 1):2244-7. doi: 10.1097/01.ju.0000090965.71697.37. J Urol. 2003. PMID: 14634389

5

Preoperative plasma soluble E-cadherin predicts metastases to lymph nodes and prognosis in patients undergoing radical cystectomy.

Matsumoto K, Shariat SF, Casella R, Wheeler TM, Slawin KM, Lerner SP. Matsumoto K, et al. Among authors: shariat sf. J Urol. 2003 Dec;170(6 Pt 1):2248-52. doi: 10.1097/01.ju.0000094189.93805.17. J Urol. 2003. PMID: 14634390

6

Urine detection of survivin is a sensitive marker for the noninvasive diagnosis of bladder cancer.

Shariat SF, Casella R, Khoddami SM, Hernandez G, Sulser T, Gasser TC, Lerner SP. Shariat SF, et al. J Urol. 2004 Feb;171(2 Pt 1):626-30. doi: 10.1097/01.ju.0000107826.78479.90. J Urol. 2004. PMID: 14713774

7

Risk stratification for bladder tumor recurrence, stage and grade by urinary nuclear matrix protein 22 and cytology.

Shariat SF, Casella R, Wians FH Jr, Ashfaq R, Balko J, Sulser T, Gasser TC, Sagalowsky AI. Shariat SF, et al. Eur Urol. 2004 Mar;45(3):304-13; author reply 313. doi: 10.1016/j.eururo.2003.10.020. Eur Urol. 2004. PMID: 15036675

8

The percent of biopsy cores positive for cancer is a predictor of advanced pathological stage and poor clinical outcomes in patients treated with radical prostatectomy.

Lotan Y, Shariat SF, Khoddami SM, Saboorian H, Koeneman KS, Cadeddu JA, Sagalowsky AI, McConnell JD, Roehrborn CG. Lotan Y, et al. Among authors: shariat sf. J Urol. 2004 Jun;171(6 Pt 1):2209-14. doi: 10.1097/01.ju.0000127730.78973.fe. J Urol. 2004. PMID: 15126787

9

Predictive value of primary Gleason pattern 4 in patients with Gleason score 7 tumours treated with radical prostatectomy.

Khoddami SM, Shariat SF, Lotan Y, Saboorian H, McConnell JD, Sagalowsky AI, Roehrborn CG, Koeneman KS. Khoddami SM, et al. Among authors: shariat sf. BJU Int. 2004 Jul;94(1):42-6. doi: 10.1111/j.1464-410X.2004.04898.x. BJU Int. 2004. PMID: 15217428

10

Reliability of remembered International Index of Erectile Function domain scores in men with localized prostate cancer.

Karakiewicz P, Shariat SF, Naderi A, Kadmon D, Slawin KM. Karakiewicz P, et al. Among authors: shariat sf. Urology. 2005 Jan;65(1):131-5. doi: 10.1016/j.urology.2004.08.054. Urology. 2005. PMID: 15667878

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,908 results

Search Page

Filters